FDA Inspection 1038905 — IMRIS Imaging Inc

IMRIS Imaging Inc — FEI 3010326005

The FDA completed an inspection of IMRIS Imaging Inc on Jan 26, 2018 in Chaska, MN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 26, 2018
Fiscal Year
2018
Product Type
Devices
Project Area
Compliance: Devices
Location
Chaska, MN (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
367821 CFR 820.30(g)Design Validation - Risk analysis not performed/inadequate
419121 CFR 806.10(a)(1)Report of risk to health
73221 CFR 803.50(a)(2)Individual Report of Malfunction

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.